A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

NCT06013241 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis Without Nasal Polyps

Interventions

DRUG: Brensocatib
DRUG: Placebo
DRUG: Mometasone furoate nasal spray (MFNS)

Sponsor

Insmed Incorporated